TACHYON THERAPEUTICS
Tachyon Therapeutics develops novel, selective compounds to improve the treatment of cancer. The company is currently conducting Phase 1 clinical research in patients with advanced cancer to assess the safety, pharmacokinetics, and anti-tumor effectiveness of TACH101. The programs will be advanced in a timely, innovative, high-quality, and scientifically sound manner.
TACHYON THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Life Science Medical
Founded:
2019-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.tachyontx.com
Total Employee:
1+
Status:
Active
Contact:
(628) 216-5899
Email Addresses:
[email protected]
Total Funding:
18.7 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Tag Manager Apple Mobile Web Clips Icon Google Font API Google Analytics WordPress Content Delivery Network Global Site Tag ReCAPTCHA
Similar Organizations
Carisma Therapeutics
Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.
Clade Therapeutics
Clade Therapeutics discovers and delivers next-generation cell medicines to improve the lives of patients.
Eikon Therapeutics
Eikon Therapeutics is a biopharmaceutical company that develops live-cell resolution microscopy and engineering for drug discovery.
Novasenta
Novasenta develops treatments to transform the lives of patients with cancer.
Renovacor
Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.
Rondo Therapeutics
Rondo Therapeutics creates novel bispecific antibodies that activate the immune system to fight cancer.
Tr1x
Tr1x develops universal cellular therapies intended for the treatment of autoimmune disorders.
Current Advisors List
Current Employees Featured
Founder
Investors List
Veblen Ventures
Veblen Ventures investment in Series A - Tachyon Therapeutics
Khosla Ventures
Khosla Ventures investment in Series A - Tachyon Therapeutics
California Institute for Regenerative Medicine
California Institute for Regenerative Medicine investment in Grant - Tachyon Therapeutics
Red Tree Venture Capital
Red Tree Venture Capital investment in Series A - Tachyon Therapeutics
Official Site Inspections
http://www.tachyontx.com Semrush global rank: 16.13 M Semrush visits lastest month: 1
- Host name: 72.0.153.160.host.secureserver.net
- IP address: 160.153.0.72
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Tachyon Therapeutics"
Tachyon Therapeutics - Crunchbase Company Profile
Organization. Tachyon Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ...See details»
Tachyon Therapeutics - LinkedIn
Tachyon Therapeutics | 424 followers on LinkedIn. Tachyon is advancing novel first-in-class compounds against significant new drug targets for treatments against cancer. | Tachyon is accelerating ...See details»
Tachyon - 2025 Company Profile, Funding & Competitors - Tracxn
Feb 25, 2025 Tachyon - Developer of therapeutics for cancer. Raised a total funding of $11.6M over 2 rounds from 4 investors. Tachyon has 2903 competitors.See details»
Tachyon Therapeutics Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Tachyon Therapeutics Inc. of Palo Alto, CA. Get the latest business insights from Dun & Bradstreet.See details»
Tachyon Therapeutics Inc. Company Profile - Dun & Bradstreet
Tachyon Therapeutics Inc. Company Profile | Houston, TX | Competitors, Financials & Contacts - Dun & BradstreetSee details»
Tachyon Announces Financing and Start of Clinical Study of
Mar 1, 2023 SAN FRANCISCO & HOUSTON--(BUSINESS WIRE)-- Tachyon Therapeutics, Inc. (“Tachyon” or “the Company”), a private, clinical-stage biotechnology company developing …See details»
Tachyon Therapeutics - Products, Competitors, Financials, …
Mar 2, 2023 Headquarters Location. 2925 Richmond Ave Suite 1200. Houston, Texas, 77098, United States. 832-952-0829See details»
Tachyon Therapeutics - Overview, News & Similar companies
Who is Tachyon Therapeutics. Tachyon Therapeutics, Inc. develops first-in-class therapeutics against novel targets from previously unexplored cancer dysregulation pathways to p ropel …See details»
Tachyon Therapeutics Overview | SignalHire Company Profile
Organization Website. tachyontx.com . Tachyon Therapeutics industries. Biotech Headquarters Location. 1160 Battery Street East, San Francisco, CA, 94111 US. Tachyon Therapeutics …See details»
Tachyon Therapeutics Company Profile -Sales, Contacts, …
Tachyon Therapeutics is in the Biotechnical Research, Commercial industry within the Engineering, Accounting, Research, and Management Services sector and has been in …See details»
Tachyon Receives Funding from CIRM for a Phase 1 …
Mar 1, 2023 Contacts. Investor & Company Contact: Frank Perabo, Chief Executive Officer, +1(832)952-0829, [email protected] Media Contact: Jessica Yingling, Ph.D., Little Dog ...See details»
Orphanet: Tachyon Therapeutics, Inc.
Knowledge on rare diseases and orphan drugs COVID-19 & Rare diseases Rare Diseases Resources for Refugees/Displaced PersonsSee details»
Tachyon Presents Promising Preclinical Data on Its First-in-class …
Apr 10, 2021 For more information, please visit www.tachyontx.com. Further Information. For further information about the Company or Investor information please contact: Frank Perabo, ...See details»
Tachyon Receives Funding from CIRM for a Phase 1 Clinical Study …
Mar 1, 2023 SAN FRANCISCO & HOUSTON--(BUSINESS WIRE)-- Tachyon Therapeutics, Inc. ("Tachyon" or "the Company"), a private, clinical-stage biotechnology company developing …See details»
AbCellera Biologics Inc. - Tachyon and AbCellera Collaborate to …
Aug 3, 2021 Tachyon operates with a dedicated internal core development team and a virtual external network of expertise to achieve one goal – advance development of promising drug …See details»
Tachyon Receives Funding from CIRM for a Phase 1 Clinical
Mar 1, 2023 SAN FRANCISCO & HOUSTON--(BUSINESS WIRE)-- Tachyon Therapeutics, Inc. (“Tachyon” or “the Company”), a private, clinical-stage biotechnology company developing …See details»
Tachyon Announces Financing and Start of Clinical Study of First …
Mar 1, 2023 SAN FRANCISCO & HOUSTON--(BUSINESS WIRE)-- Tachyon Therapeutics, Inc. ("Tachyon" or "the Company"), a private, clinical-stage biotechnology company developing …See details»
Tachyon Receives IND Clearance from FDA to Develop Novel …
Aug 24, 2022 HOUSTON--(BUSINESS WIRE)-- Tachyon Therapeutics, Inc. ("Tachyon" or "the Company"), a private biotechnology company developing transformative cancer therapies …See details»
Tachyon Announces Presentations at the ASCO Annual Meeting
Jun 4, 2021 HOUSTON--(BUSINESS WIRE)--Tachyon Therapeutics, Inc. ("Tachyon" or "the Company"), a research and development biotechnology company, today announced two …See details»
Scoop: Ken Paxton hires consultants for 2026 Texas Senate …
7 hours ago Texas Attorney General Ken Paxton has hired the prominent Republican consulting firm Axiom Strategies to run his primary campaign against GOP Sen. John Cornyn, according …See details»